文献速递骨质疏松与代谢性骨病创伤骨科

成人低磷酸酯酶症患者的骨密度与骨折风险

Bone mineral density and fracture risk in adult patients with hypophosphatasia.
PubMed 文献 · Osteoporos Int · 2020-09-02

回顾性单中心分析110例确诊成人低磷酸酯酶症(HPP)患者的双能X线吸收测定(DXA)扫描,腰椎T值平均-0.1(标准差1.9),全髋T值平均-1.07(标准差0.15)。较低碱性磷酸酶活性和较高底物水平与腰椎T值升高显著相关(p<0.001),腰椎骨密度升高与HPP相关骨折风险增加显著相关(p<0.001),而髋部骨密度不受疾病严重程度指标影响。

要点

  • 成人HPP患者骨密度并非系统性降低,腰椎T值平均-0.1(标准差1.9),全髋T值平均-1.07(标准差0.15)。
  • 较低碱性磷酸酶活性和较高吡哆醛磷酸及磷酸乙醇胺水平与腰椎T值升高显著相关(p<0.001)。
  • 腰椎骨密度升高与HPP相关骨折风险增加显著相关(p<0.001),22例(20%)患者存在HPP相关骨折。

核心结论

  • 成人HPP患者骨密度并非系统性降低,腰椎骨密度升高似乎与矿化严重受损及HPP相关骨折风险增加相关。
  • 髋部骨密度似乎不受疾病严重程度指标影响,提示该解剖部位可能适合评估和辨别因骨密度降低导致骨折风险增加的疾病如骨质疏松。

研究设计与样本

  • 回顾性单中心分析,纳入110例确诊HPP患者(84例女性,平均年龄46.2岁),其中37.3%(n=41)携带两个突变。
  • 研究评估DXA扫描、疾病相关骨折、实验室结果(碱性磷酸酶、吡哆醛磷酸、磷酸乙醇胺)及病史。
  • 试验注册号:德国临床研究注册库(DRKS00014022),注册日期2018年10月2日,回顾性注册。

主要发现

  • 腰椎平均T值为-0.1(标准差1.9),全髋平均T值为-1.07(标准差0.15)。
  • 较低碱性磷酸酶活性和较高底物水平(吡哆醛磷酸和磷酸乙醇胺)与腰椎T值升高显著相关(p<0.001),而髋部骨密度不受疾病严重程度指标影响。
  • 腰椎骨密度升高与HPP相关骨折风险增加显著相关(p<0.001),HPP相关骨折见于22例(20%)患者,其中21例携带双等位基因突变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: In adult hypophosphatasia (HPP) patients, elevated lumbar spine dual X-ray absorptiometry (DXA) values are associated with markers of disease severity and disease-specific fracture risk while femoral bone mineral density (BMD), being largely unaffected by the disease severity, may still be useful to monitor other causes of increased fracture risk due to low BMD. INTRODUCTION: Hypophosphatasia (HPP) is a rare inherited metabolic disorder due to deficient activity of the tissue-nonspecific alkaline phosphatase (TNAP). Clinical manifestation in adult HPP patients is manifold including an increased risk for fractures, but data regarding clinical significance of DXA measurement and associations with fracture risk and disease severity is scarce. METHODS: Retrospective single-center analysis of DXA scans in patients with confirmed HPP (documented mutation, clinical symptoms, low alkaline phosphatase activity). Further data evaluation included disease-related fractures, laboratory results (alkaline phosphatase, pyridoxalphosphate, phosphoethanolamine), and medical history. RESULTS: Analysis included 110 patients (84 female, mean age of 46.2 years) of whom 37.3% (n = 41) were harboring two mutations. Average T-Score level at the lumbar spine was - 0.1 (SD 1.9), and mean total hip T-Score was - 1.07 (SD 0.15). Both lower ALP activity and higher substrate levels (pyridoxalphosphate and phosphoethanolamine) were significantly correlated with increased lumbar spine T-Score levels (p < 0.001) while BMD at the hip was not affected by indicators of disease severity. Increased lumbar spine BMD was significantly associated with an increased risk for HPP-related fractures, prevalent in 22 (20%) patients (p < 0.001) with 21 of them having biallelic mutations. CONCLUSION: BMD in adult HPP patients is not systematically reduced. Conversely, increased lumbar spine BMD appears to be associated with severely compromised mineralization and increased risk for HPP-related fractures while BMD at the hip appears unaffected by indicators of disease severity, suggesting suitability of this anatomic location for assessing and discerning disorders with increased fracture risk owing to reduced BMD like osteoporosis. TRIAL REGISTRATION NUMBER: German register for clinical studies (DRKS00014022) DATE OF REGISTRATION: 02/10/2018 - retrospectively registered.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Genest F, Claußen L, Rak D, et al. Bone mineral density and fracture risk in adult patients with hypophosphatasia. Osteoporos Int. 2020. PMID: 32879991. doi:10.1007/s00198-020-05612-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。